{
  "trial_id": "NCT04601298",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Clinical cytology diagnosis of Bethesda category III (AUS/FLUS) pathological confirmation",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "of thyroid malignancy after surgery.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "pathological confirmation of other thyroid carcinomas, including follicular carcinoma",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "medullary carcinoma",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "undifferentiated Spindle cell carcinoma and lymphoma were excluded",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "female who were pregnant were excluded",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "patients with mental disorders were excluded",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "patients without the complete clinical data were excluded",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has metastatic papillary thyroid cancer and underwent XRT, which may be relevant for trial eligibility.",
  "_meta": {
    "topic_id": "11",
    "trial_id": "NCT04601298",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}